Rupesh Kumar Tyagi (born 1 January 1983) is a biotechnologist. He has a doctorate in biotechnology from the All India Institute of Medical Sciences(1,2,3). He was the chairman of Society of Young Scientist (SYS) from 2011-2012. Publications *Alam MS, Rathore S, Tyagi RK, Sharma YD, [http://www.ncbi.nlm.nih.gov/pubmed/26823170 "Host-parasite interaction: multiple sites in the Plasmodium vivax tryptophan-rich antigen PvTRAg38 interact with the erythrocyte receptor band 3."], FEBS Lett. (2016) 590(2):232-41. doi: 10.1002/1873-3468.12053. Epub 2016 Jan 23. *Tyagi K, Gupta D, Saini E, Choudhary S, Jamwal A, Alam MS, Zeeshan M, Tyagi RK, Sharma YD, "Recognition of Human Erythrocyte Receptors by the Tryptophan-Rich Antigens of Monkey Malaria Parasite Plasmodium knowlesi.", PLoS ONE (2015) 10(9): e0138691. doi:10.1371/journal.pone.0138691 *Alam MS, Choudhary V, Zeeshan M, Tyagi RK, Rathore S, Sharma YD, [http://www.ncbi.nlm.nih.gov/pubmed/26149684 "Interaction of Plasmodium vivax Tryptophan-rich Antigen PvTRAg38 with Band 3 on Human Erythrocyte Surface Facilitates Parasite Growth"], J. Biol. Chem. (2015) 290: 20257-20272 *Zeeshan M, Tyagi RK, Tyagi K, Alam MS, Sharma YD, [http://jid.oxfordjournals.org/content/211/7/1111.full.pdf+html "Host-parasite interaction: selective Pv-fam-a family proteins of Plasmodium vivax bind to a restricted number of human erythrocyte receptors."], J Infect Dis. (2015) 211 (7): 1111-1120. doi: 10.1093/infdis/jiu558 *Bora H, Rupesh Kumar Tyagi RK, Sharma YD, [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0062829 "Defining the erythrocyte binding domains of Plasmodium vivax tryptophan rich antigen 33.5."], PLoS ONE (2013) 8(4): e62829. doi: 10.1371/journal.pone.0062829 *Tyagi1 RK, Das MJ, Singh SS, Sharma YD, [ "Discordance in drug resistance-associated mutation patterns in marker genes of Plasmodium falciparum and Plasmodium knowlesi during coinfections."], J. Antimicrob. Chemother. (2013) 68 (5): 1081-1088. doi: 10.1093/jac/dks508 *Tyagi RK, Sharma YD, "Erythrocyte Binding Activity Displayed by a Selective Group of Plasmodium vivax Tryptophan Rich Antigens Is Inhibited by Patients' Antibodies.", PLoS ONE (2012) 7(12): e50754. doi: 10.1371/journal.pone.0050754 *Zeeshan M, Alam MT, Vinayak S, Bora H, Tyagi RK, Alam MS, Choudhary V, Mittra P, Vanshika Lumb V, Bharti PK, Udhayakumar V, Singh N, Jain V, Singh PP, Sharma YD, "Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine.", PLoS ONE (2012) 7(8): e43430. doi: 10.1371/journal.pone.0043430
|
|
|